Our findings suggest that AMY1 CNVs may be associated not only with obesity, but also with increased cardiovascular risk and chronic low-grade inflammation in overweight or obese individuals. The gene discussed is AMY1A; the disease is obesity due to melanocortin 4 receptor deficiency.